Sponsored Ad
Search Results

(±)-Zanubrutinib 10 mg  | 98.19%

TargetMol

(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.

More Information Supplier Page

(±)-Zanubrutinib 50 mg  | 98.19%

TargetMol

(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.

More Information Supplier Page

(±)-Zanubrutinib 1 mL  | 98.19%

TargetMol

(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.

More Information Supplier Page

(±)-Zanubrutinib 1 mg  | 98.19%

TargetMol

(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.

More Information Supplier Page

(±)-Zanubrutinib 25 mg  | 98.19%

TargetMol

(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.

More Information Supplier Page

(±)-Zanubrutinib 100 mg  | 98.19%

TargetMol

(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.

More Information Supplier Page

(±)-Zanubrutinib 500 mg  | 98.19%

TargetMol

(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.

More Information Supplier Page